PCNA, which is a marker of proliferation, was down-regulated in tumor tissues in SYY treated group (HCCLM3 + HSC 22880 ± 1510 vs. HCCLM3 + HSC + SYY 15240 ± 1050, P = 0.0143). This evidence concerns the gene PCNA and neoplasm.